A First Time in Human Study of GSK586529 in Healthy Volunteers
Status:
Completed
Trial end date:
2008-04-11
Target enrollment:
Participant gender:
Summary
A single blind, randomized, placebo-controlled, crossover study in twenty four healthy male
subjects. Subjects will be divided into two cohorts with alternate panel design. The study is
investigating the safety, tolerability and pharmacokinetics of single oral escalating doses
of GSK586529.